Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Psychedelics and the essential importance of context
Robin Carhart‐Harris, Leor Roseman, Eline Haijen, et al.
Journal of Psychopharmacology (2018) Vol. 32, Iss. 7, pp. 725-731
Closed Access | Times Cited: 511

Showing 1-25 of 511 citing articles:

Trial of Psilocybin versus Escitalopram for Depression
Robin Carhart‐Harris, Bruna Giribaldi, Rosalind Watts, et al.
New England Journal of Medicine (2021) Vol. 384, Iss. 15, pp. 1402-1411
Open Access | Times Cited: 1007
REBUS and the Anarchic Brain: Toward a Unified Model of the Brain Action of Psychedelics
Robin Carhart‐Harris, Karl Friston
Pharmacological Reviews (2019) Vol. 71, Iss. 3, pp. 316-344
Open Access | Times Cited: 784
Quality of Acute Psychedelic Experience Predicts Therapeutic Efficacy of Psilocybin for Treatment-Resistant Depression
Leor Roseman, David Nutt, Robin Carhart‐Harris
Frontiers in Pharmacology (2018) Vol. 8
Open Access | Times Cited: 646
The entropic brain - revisited
Robin Carhart‐Harris
Neuropharmacology (2018) Vol. 142, pp. 167-178
Closed Access | Times Cited: 434
Psychedelic effects of psilocybin correlate with serotonin 2A receptor occupancy and plasma psilocin levels
M. Madsen, Patrick M. Fisher, Daniel Burmester, et al.
Neuropsychopharmacology (2019) Vol. 44, Iss. 7, pp. 1328-1334
Open Access | Times Cited: 379
Predicting Responses to Psychedelics: A Prospective Study
Eline Haijen, Mendel Kaelen, Leor Roseman, et al.
Frontiers in Pharmacology (2018) Vol. 9
Open Access | Times Cited: 325
Increased global integration in the brain after psilocybin therapy for depression
Richard E. Daws, Christopher Timmermann, Bruna Giribaldi, et al.
Nature Medicine (2022) Vol. 28, Iss. 4, pp. 844-851
Open Access | Times Cited: 312
Psychedelics, Meditation, and Self-Consciousness
Raphaël Millière, Robin Carhart‐Harris, Leor Roseman, et al.
Frontiers in Psychology (2018) Vol. 9
Open Access | Times Cited: 310
Emotional breakthrough and psychedelics: Validation of the Emotional Breakthrough Inventory
Leor Roseman, Eline Haijen, Kelvin Idialu-Ikato, et al.
Journal of Psychopharmacology (2019) Vol. 33, Iss. 9, pp. 1076-1087
Closed Access | Times Cited: 294
Cessation and reduction in alcohol consumption and misuse after psychedelic use
Albert Garcia‐Romeu, Alan K. Davis, Fire Erowid, et al.
Journal of Psychopharmacology (2019) Vol. 33, Iss. 9, pp. 1088-1101
Closed Access | Times Cited: 224
Blinding and expectancy confounds in psychedelic randomized controlled trials
Suresh Muthukumaraswamy, Anna Forsyth, Thomas Lumley
Expert Review of Clinical Pharmacology (2021) Vol. 14, Iss. 9, pp. 1133-1152
Closed Access | Times Cited: 212
Brain States and Transitions: Insights from Computational Neuroscience
Morten L. Kringelbach, Gustavo Deco
Cell Reports (2020) Vol. 32, Iss. 10, pp. 108128-108128
Open Access | Times Cited: 211
Whole-Brain Multimodal Neuroimaging Model Using Serotonin Receptor Maps Explains Non-linear Functional Effects of LSD
Gustavo Deco, Josephine Cruzat, Joana Cabral, et al.
Current Biology (2018) Vol. 28, Iss. 19, pp. 3065-3074.e6
Open Access | Times Cited: 202
The use of the psychological flexibility model to support psychedelic assisted therapy
Rosalind Watts, Jason B. Luoma
Journal of Contextual Behavioral Science (2019) Vol. 15, pp. 92-102
Closed Access | Times Cited: 193
DMT Models the Near-Death Experience
Christopher Timmermann, Leor Roseman, L. Williams, et al.
Frontiers in Psychology (2018) Vol. 9
Open Access | Times Cited: 191
Long-term effects of psychedelic drugs: A systematic review
Jacob S. Aday, Cayla M. Mitzkovitz, Emily K. Bloesch, et al.
Neuroscience & Biobehavioral Reviews (2020) Vol. 113, pp. 179-189
Closed Access | Times Cited: 188
Hallucinogens in Mental Health: Preclinical and Clinical Studies on LSD, Psilocybin, MDMA, and Ketamine
Danilo De Gregorio, Argel Aguilar‐Valles, Katrin H. Preller, et al.
Journal of Neuroscience (2020) Vol. 41, Iss. 5, pp. 891-900
Open Access | Times Cited: 188
Predicting Reactions to Psychedelic Drugs: A Systematic Review of States and Traits Related to Acute Drug Effects
Jacob S. Aday, Alan K. Davis, Cayla M. Mitzkovitz, et al.
ACS Pharmacology & Translational Science (2021) Vol. 4, Iss. 2, pp. 424-435
Open Access | Times Cited: 168
Psychedelic Treatments for Psychiatric Disorders: A Systematic Review and Thematic Synthesis of Patient Experiences in Qualitative Studies
Joost J. Breeksema, Alistair Niemeijer, Erwin Krediet, et al.
CNS Drugs (2020) Vol. 34, Iss. 9, pp. 925-946
Open Access | Times Cited: 167
Therapeutic mechanisms of psilocybin: Changes in amygdala and prefrontal functional connectivity during emotional processing after psilocybin for treatment-resistant depression
Lea J. Mertens, Matthew B. Wall, Leor Roseman, et al.
Journal of Psychopharmacology (2020) Vol. 34, Iss. 2, pp. 167-180
Closed Access | Times Cited: 153
Psychedelic Communitas: Intersubjective Experience During Psychedelic Group Sessions Predicts Enduring Changes in Psychological Wellbeing and Social Connectedness
Hannes Kettner, Fernando Rosas, Christopher Timmermann, et al.
Frontiers in Pharmacology (2021) Vol. 12
Open Access | Times Cited: 152
Ketamine Assisted Psychotherapy (KAP): Patient Demographics, Clinical Data and Outcomes in Three Large Practices Administering Ketamine with Psychotherapy
Jennifer Dore, Brent Turnipseed, Shannon Dwyer, et al.
Journal of Psychoactive Drugs (2019) Vol. 51, Iss. 2, pp. 189-198
Open Access | Times Cited: 147
Therapeutic Alliance and Rapport Modulate Responses to Psilocybin Assisted Therapy for Depression
Roberta Murphy, Hannes Kettner, Rick Zeifman, et al.
Frontiers in Pharmacology (2022) Vol. 12
Open Access | Times Cited: 144
Learning to Let Go: A Cognitive-Behavioral Model of How Psychedelic Therapy Promotes Acceptance
Max Wolff, Ricarda Evens, Lea J. Mertens, et al.
Frontiers in Psychiatry (2020) Vol. 11
Open Access | Times Cited: 141
Self-blinding citizen science to explore psychedelic microdosing
Balázs Szigeti, Laura Kärtner, Allan Blemings, et al.
eLife (2021) Vol. 10
Open Access | Times Cited: 139
Page 1 - Next Page

Scroll to top